sureselect Search Results


97
Sophia Genetics clinical exome solution kit
Clinical Exome Solution Kit, supplied by Sophia Genetics, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clinical exome solution kit/product/Sophia Genetics
Average 97 stars, based on 1 article reviews
clinical exome solution kit - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

97
Sophia Genetics solid tumor solutiontm
Solid Tumor Solutiontm, supplied by Sophia Genetics, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/solid tumor solutiontm/product/Sophia Genetics
Average 97 stars, based on 1 article reviews
solid tumor solutiontm - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

97
Sophia Genetics alamut visual plus software
Potential consequences of genetic changes in clone 1.5. and investigation of mRNA products via RT-PCR. (A) Sequencing of clone 1.5 gDNA showed a huge genetic alteration within the ALPL exon 6 locus, including a 48 <t>bp</t> <t>duplication</t> and a 48 bp deletion. Clonal cDNA sequencing further clarified that the deletion results in an in-frame loss of 48 bp, thereby subsequently should result in loss of 16 aa within the corresponding TNAP protein domain. The corresponding insertion is not detected in the cDNA sequencing. (B) A potential gain of a novel splice acceptor site was predicted by different algorithms <t>(Alamut</t> Visual Plus splice summary is shown, blue box marks ALPL exon 6 locus, red box indicates gained sequence, green box marks novel splice site). (C) The in silico predicted novel splice product was detectable via RT-PCR by electrophoresis. The analyses indicate an additional PCR product in clone 1.5. While the larger product (marked with white arrowhead) is also present in clone 1.3, the smaller band was only detected in clone 1.5 (marked with green arrowhead). (D) Sequencing of the smaller RT-PCR products shows deletion of 48 bp and the active usage of the new splice site. (E) Schematic presentation of sequence aberration and splice prediction for the wildtype and the aberrant sequence on gDNA (upper panel) and mRNA level (lower panel). PCR primer binding sites and expected RT-PCR product sites (in grey) are in addition sketched below. The CRISPR target region is marked in red. The green box marks 48 bp duplication in clone 1.5, while the crossed white box indicates deletion of 48 bp. Black asterisk marks position of potential novel splice site.
Alamut Visual Plus Software, supplied by Sophia Genetics, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alamut visual plus software/product/Sophia Genetics
Average 97 stars, based on 1 article reviews
alamut visual plus software - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

97
Sophia Genetics hereditary cancer solution
Potential consequences of genetic changes in clone 1.5. and investigation of mRNA products via RT-PCR. (A) Sequencing of clone 1.5 gDNA showed a huge genetic alteration within the ALPL exon 6 locus, including a 48 <t>bp</t> <t>duplication</t> and a 48 bp deletion. Clonal cDNA sequencing further clarified that the deletion results in an in-frame loss of 48 bp, thereby subsequently should result in loss of 16 aa within the corresponding TNAP protein domain. The corresponding insertion is not detected in the cDNA sequencing. (B) A potential gain of a novel splice acceptor site was predicted by different algorithms <t>(Alamut</t> Visual Plus splice summary is shown, blue box marks ALPL exon 6 locus, red box indicates gained sequence, green box marks novel splice site). (C) The in silico predicted novel splice product was detectable via RT-PCR by electrophoresis. The analyses indicate an additional PCR product in clone 1.5. While the larger product (marked with white arrowhead) is also present in clone 1.3, the smaller band was only detected in clone 1.5 (marked with green arrowhead). (D) Sequencing of the smaller RT-PCR products shows deletion of 48 bp and the active usage of the new splice site. (E) Schematic presentation of sequence aberration and splice prediction for the wildtype and the aberrant sequence on gDNA (upper panel) and mRNA level (lower panel). PCR primer binding sites and expected RT-PCR product sites (in grey) are in addition sketched below. The CRISPR target region is marked in red. The green box marks 48 bp duplication in clone 1.5, while the crossed white box indicates deletion of 48 bp. Black asterisk marks position of potential novel splice site.
Hereditary Cancer Solution, supplied by Sophia Genetics, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hereditary cancer solution/product/Sophia Genetics
Average 97 stars, based on 1 article reviews
hereditary cancer solution - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

99
Illumina Inc rna library preparation kit for illumina multiplexed sequencing
Potential consequences of genetic changes in clone 1.5. and investigation of mRNA products via RT-PCR. (A) Sequencing of clone 1.5 gDNA showed a huge genetic alteration within the ALPL exon 6 locus, including a 48 <t>bp</t> <t>duplication</t> and a 48 bp deletion. Clonal cDNA sequencing further clarified that the deletion results in an in-frame loss of 48 bp, thereby subsequently should result in loss of 16 aa within the corresponding TNAP protein domain. The corresponding insertion is not detected in the cDNA sequencing. (B) A potential gain of a novel splice acceptor site was predicted by different algorithms <t>(Alamut</t> Visual Plus splice summary is shown, blue box marks ALPL exon 6 locus, red box indicates gained sequence, green box marks novel splice site). (C) The in silico predicted novel splice product was detectable via RT-PCR by electrophoresis. The analyses indicate an additional PCR product in clone 1.5. While the larger product (marked with white arrowhead) is also present in clone 1.3, the smaller band was only detected in clone 1.5 (marked with green arrowhead). (D) Sequencing of the smaller RT-PCR products shows deletion of 48 bp and the active usage of the new splice site. (E) Schematic presentation of sequence aberration and splice prediction for the wildtype and the aberrant sequence on gDNA (upper panel) and mRNA level (lower panel). PCR primer binding sites and expected RT-PCR product sites (in grey) are in addition sketched below. The CRISPR target region is marked in red. The green box marks 48 bp duplication in clone 1.5, while the crossed white box indicates deletion of 48 bp. Black asterisk marks position of potential novel splice site.
Rna Library Preparation Kit For Illumina Multiplexed Sequencing, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rna library preparation kit for illumina multiplexed sequencing/product/Illumina Inc
Average 99 stars, based on 1 article reviews
rna library preparation kit for illumina multiplexed sequencing - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
Illumina Inc wes-sureselct illumina
(A) Novel mutations or novel phenotypes in known mitochondrial disease genes affecting oxidative phosphorylation identified using NGS methods. (B) Novel mutations or novel phenotypes in known mitochondrial disease genes not affecting oxidative phosphorylation identified using NGS methods
Wes Sureselct Illumina, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wes-sureselct illumina/product/Illumina Inc
Average 90 stars, based on 1 article reviews
wes-sureselct illumina - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Illumina Inc sureselect human all exon system
(A) Novel mutations or novel phenotypes in known mitochondrial disease genes affecting oxidative phosphorylation identified using NGS methods. (B) Novel mutations or novel phenotypes in known mitochondrial disease genes not affecting oxidative phosphorylation identified using NGS methods
Sureselect Human All Exon System, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureselect human all exon system/product/Illumina Inc
Average 90 stars, based on 1 article reviews
sureselect human all exon system - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Illumina Inc sureselect exome v3 baits
(A) Novel mutations or novel phenotypes in known mitochondrial disease genes affecting oxidative phosphorylation identified using NGS methods. (B) Novel mutations or novel phenotypes in known mitochondrial disease genes not affecting oxidative phosphorylation identified using NGS methods
Sureselect Exome V3 Baits, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureselect exome v3 baits/product/Illumina Inc
Average 90 stars, based on 1 article reviews
sureselect exome v3 baits - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
RainDance Technologies sureselect
(A) Novel mutations or novel phenotypes in known mitochondrial disease genes affecting oxidative phosphorylation identified using NGS methods. (B) Novel mutations or novel phenotypes in known mitochondrial disease genes not affecting oxidative phosphorylation identified using NGS methods
Sureselect, supplied by RainDance Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureselect/product/RainDance Technologies
Average 90 stars, based on 1 article reviews
sureselect - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Illumina Inc polya illumina sureselect strand specific rna library prep
RNA-seq datasets from progeria patients used in this study.
Polya Illumina Sureselect Strand Specific Rna Library Prep, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polya illumina sureselect strand specific rna library prep/product/Illumina Inc
Average 90 stars, based on 1 article reviews
polya illumina sureselect strand specific rna library prep - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Illumina Inc sureselect human all exon v6+cosmic
RNA-seq datasets from progeria patients used in this study.
Sureselect Human All Exon V6+Cosmic, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureselect human all exon v6+cosmic/product/Illumina Inc
Average 90 stars, based on 1 article reviews
sureselect human all exon v6+cosmic - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Illumina Inc sureselect
RNA-seq datasets from progeria patients used in this study.
Sureselect, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sureselect/product/Illumina Inc
Average 90 stars, based on 1 article reviews
sureselect - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Potential consequences of genetic changes in clone 1.5. and investigation of mRNA products via RT-PCR. (A) Sequencing of clone 1.5 gDNA showed a huge genetic alteration within the ALPL exon 6 locus, including a 48 bp duplication and a 48 bp deletion. Clonal cDNA sequencing further clarified that the deletion results in an in-frame loss of 48 bp, thereby subsequently should result in loss of 16 aa within the corresponding TNAP protein domain. The corresponding insertion is not detected in the cDNA sequencing. (B) A potential gain of a novel splice acceptor site was predicted by different algorithms (Alamut Visual Plus splice summary is shown, blue box marks ALPL exon 6 locus, red box indicates gained sequence, green box marks novel splice site). (C) The in silico predicted novel splice product was detectable via RT-PCR by electrophoresis. The analyses indicate an additional PCR product in clone 1.5. While the larger product (marked with white arrowhead) is also present in clone 1.3, the smaller band was only detected in clone 1.5 (marked with green arrowhead). (D) Sequencing of the smaller RT-PCR products shows deletion of 48 bp and the active usage of the new splice site. (E) Schematic presentation of sequence aberration and splice prediction for the wildtype and the aberrant sequence on gDNA (upper panel) and mRNA level (lower panel). PCR primer binding sites and expected RT-PCR product sites (in grey) are in addition sketched below. The CRISPR target region is marked in red. The green box marks 48 bp duplication in clone 1.5, while the crossed white box indicates deletion of 48 bp. Black asterisk marks position of potential novel splice site.

Journal: Frontiers in Cell and Developmental Biology

Article Title: Establishment of human periodontal ligament cell lines with ALPL mutations to mimic dental aspects of hypophosphatasia

doi: 10.3389/fcell.2025.1572571

Figure Lengend Snippet: Potential consequences of genetic changes in clone 1.5. and investigation of mRNA products via RT-PCR. (A) Sequencing of clone 1.5 gDNA showed a huge genetic alteration within the ALPL exon 6 locus, including a 48 bp duplication and a 48 bp deletion. Clonal cDNA sequencing further clarified that the deletion results in an in-frame loss of 48 bp, thereby subsequently should result in loss of 16 aa within the corresponding TNAP protein domain. The corresponding insertion is not detected in the cDNA sequencing. (B) A potential gain of a novel splice acceptor site was predicted by different algorithms (Alamut Visual Plus splice summary is shown, blue box marks ALPL exon 6 locus, red box indicates gained sequence, green box marks novel splice site). (C) The in silico predicted novel splice product was detectable via RT-PCR by electrophoresis. The analyses indicate an additional PCR product in clone 1.5. While the larger product (marked with white arrowhead) is also present in clone 1.3, the smaller band was only detected in clone 1.5 (marked with green arrowhead). (D) Sequencing of the smaller RT-PCR products shows deletion of 48 bp and the active usage of the new splice site. (E) Schematic presentation of sequence aberration and splice prediction for the wildtype and the aberrant sequence on gDNA (upper panel) and mRNA level (lower panel). PCR primer binding sites and expected RT-PCR product sites (in grey) are in addition sketched below. The CRISPR target region is marked in red. The green box marks 48 bp duplication in clone 1.5, while the crossed white box indicates deletion of 48 bp. Black asterisk marks position of potential novel splice site.

Article Snippet: Prediction of splice site consequences after the 48 bp duplication via Alamut Visual Plus software (combining four different splice algorithms) resulted in identification of a high-scoring novel splice acceptor site in this region ( ; SpliceSite Finder score: 81.9; MaxEntScan score: 7.2; NNSPLICE score: 0.9; GeneSplicer score: 8.4).

Techniques: Reverse Transcription Polymerase Chain Reaction, Sequencing, In Silico, Electrophoresis, Binding Assay, CRISPR

(A) Novel mutations or novel phenotypes in known mitochondrial disease genes affecting oxidative phosphorylation identified using NGS methods. (B) Novel mutations or novel phenotypes in known mitochondrial disease genes not affecting oxidative phosphorylation identified using NGS methods

Journal: British Journal of Pharmacology

Article Title: Next-generation sequencing for mitochondrial disorders

doi: 10.1111/bph.12469

Figure Lengend Snippet: (A) Novel mutations or novel phenotypes in known mitochondrial disease genes affecting oxidative phosphorylation identified using NGS methods. (B) Novel mutations or novel phenotypes in known mitochondrial disease genes not affecting oxidative phosphorylation identified using NGS methods

Article Snippet: C19orf12 (Horvath et al ., 2012 ) , Mitochondrial protein of unknown function , WES-SureSelct Illumina , Brain iron accumulation with dystonia, optic atrophy and peripheral neuropathy.

Techniques: Phospho-proteomics, Sequencing, Binding Assay, Membrane

RNA-seq datasets from progeria patients used in this study.

Journal: eLife

Article Title: Transcriptional profiling of Hutchinson-Gilford Progeria syndrome fibroblasts reveals deficits in mesenchymal stem cell commitment to differentiation related to early events in endochondral ossification

doi: 10.7554/eLife.81290

Figure Lengend Snippet: RNA-seq datasets from progeria patients used in this study.

Article Snippet: AG03199 , 10 yr , F , White , polyA (Illumina SureSelect Strand Specific RNA library Prep) , Arufe , GSE113648.

Techniques: Sample Prep

RNA-seq datasets from adult controls used in this study.

Journal: eLife

Article Title: Transcriptional profiling of Hutchinson-Gilford Progeria syndrome fibroblasts reveals deficits in mesenchymal stem cell commitment to differentiation related to early events in endochondral ossification

doi: 10.7554/eLife.81290

Figure Lengend Snippet: RNA-seq datasets from adult controls used in this study.

Article Snippet: AG03199 , 10 yr , F , White , polyA (Illumina SureSelect Strand Specific RNA library Prep) , Arufe , GSE113648.

Techniques:

 RNA-seq  datasets from children controls used in this study.

Journal: eLife

Article Title: Transcriptional profiling of Hutchinson-Gilford Progeria syndrome fibroblasts reveals deficits in mesenchymal stem cell commitment to differentiation related to early events in endochondral ossification

doi: 10.7554/eLife.81290

Figure Lengend Snippet: RNA-seq datasets from children controls used in this study.

Article Snippet: AG03199 , 10 yr , F , White , polyA (Illumina SureSelect Strand Specific RNA library Prep) , Arufe , GSE113648.

Techniques: Sample Prep